TSCO
62
3
AIZ
63
6
CHRW
42
5
MU
50
3
EIX
51
-3
WFC
58
3
GS
60
-2
PCG
77
-4
URBN
70
14
MPC
38
2
HCP
62
-2
GME
60
-7
MRK
56
-7
PEP
36
3
ZTS
34
-15
SE
58
11
CI
46
-12
BBY
56
3
DIS
41
2
PFG
37
3
TSCO
62
3
AIZ
63
6
CHRW
42
5
MU
50
3
EIX
51
-3
WFC
58
3
GS
60
-2
PCG
77
-4
URBN
70
14
MPC
38
2
HCP
62
-2
GME
60
-7
MRK
56
-7
PEP
36
3
ZTS
34
-15
SE
58
11
CI
46
-12
BBY
56
3
DIS
41
2
PFG
37
3
Financhill
Back

ProShares UltraPro MidCap400 Vs. Spyre Therapeutics Industry Stock Comparison

Sell
45

UMDD
ProShares UltraPro MidCap400

Last Price:
24.05
Seasonality Move:
-1.14%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
45
ProShares UltraPro MidCap400 (UMDD) is a Sell

Is ProShares UltraPro MidCap400 a Buy, Sell or Hold?

  • The current ProShares UltraPro MidCap400 [UMDD] share price is $24.10. The Score for UMDD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • UMDD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UMDD Stock Price Chart

What is ProShares UltraPro MidCap400's stock price today?

  • The ProShares UltraPro MidCap400 share price today is $24.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UMDD is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

UMDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 45.12 Sell
Chaikin Money Flow: 16540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.2 - 26.48) Sell
Bollinger Bands (100): (22.8 - 26.42) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

UMDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.25 Sell
20-day SMA: 24.95 Sell
50-day SMA: 24.89 Sell
200-day SMA: 21.43 Buy
8-day EMA: 24.28 Sell
20-day EMA: 24.73 Sell
50-day EMA: 24.89 Sell
200-day EMA: 22.7 Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

ProShares UltraPro MidCap400 Earnings Growth & UMDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

ProShares UltraPro MidCap400 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):